Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
As a leading CRDMO with over three decades of experience and more than ~8,000 employees (~5500 scientists), Syngene provides end-to-end R&D and manufacturing services to global pharma/biotech clients. It has collaborations with over 400 companies worldwide—including most top pharma firms—and offers expertise across small molecules and biologics. Its platforms accelerate drug development from early research to commercial scale-up. The company does not market its own drugs but enables client pipelines across multiple therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syngene International Ltd.